Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome

Brain Research
P M Whitaker-AzmitiaE C Azmitia

Abstract

S-100 beta is a neurotrophic factor released by astroglial cells and localized to chromosome 21, within the region which is considered obligate for Down's syndrome (DS). S-100 beta is increased in the postmortem brains of both DS and Alzheimer's disease. Transgenic mice, produced by insertion of the human gene for S-100 beta, were examined for dendritic development at two ages, using an antibody against microtubule associated protein-2 (MAP-2). At the earliest stages, the density of dendrites within the hippocampus of transgenic animals exceeded that of controls. Also, MAP-2 immunostaining was evident in the region of the cell body. By 1 year of age, the transgenic animals had significant loss of dendrites compared to controls and the number of cells showing cell body staining was further increased. These pathological changes could be indicative of the presence of neurofibrillary tangles and cytoskeletal collapse. Behaviorally, younger transgenic animals could not perform in a learning task as well as controls. Together, these findings suggest that increased S-100 beta in brain may lead to accelerated development, followed by increased aging. The pathological changes may prove useful as an animal model of Down's syndrome and Al...Continue Reading

Citations

Apr 19, 2011·Journal of Speech, Language, and Hearing Research : JSLHR·Yvonne RogalskiJamie Reilly
Dec 13, 2012·American Journal of Audiology·Patricia A TunErvin R Hafter
Oct 2, 2007·Journal of Speech, Language, and Hearing Research : JSLHR·Tara Vongpaisal, Margaret Kathleen Pichora-Fuller
Feb 7, 2020·Biological Reviews of the Cambridge Philosophical Society·Jacques BaudierGary S Shaw
Oct 31, 2002·Human Psychopharmacology·Kurt Heininger
Mar 5, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthias RothermundtVolker Arolt
Aug 5, 2004·Journal of Neuropathology and Experimental Neurology·Robert E Mrak, W Sue T Griffin
Sep 8, 2006·The Journal of ECT·Baer ArtsJim van Os
Aug 25, 2006·Journal of Neurotrauma·Andrea Kleindienst, M Ross Bullock
Jan 3, 2014·Journal of Neurochemistry·Silvina TallisJuan C Perazzo
Jul 12, 2017·Nutritional Neuroscience·Nathan M D'CunhaNenad Naumovski
Oct 23, 2002·Journal of Neuroscience Research·Bruce Teter, J Wesson Ashford
Oct 29, 2010·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Pierre L Roubertoux, Michèle Carlier
Jul 16, 2010·Cardiovascular Psychiatry and Neurology·Johann SteinerBernhard Bogerts
Sep 10, 2010·Cardiovascular Psychiatry and Neurology·Guglielmo SorciRosario Donato
Nov 3, 2010·Neurosurgical Focus·Aristotelis S FilippidisKostas N Fountas
Oct 25, 2014·The Cerebellum·Björn BluhmChristian Lohr
Apr 25, 2017·The Psychiatric Quarterly·Huiqiong DengOlaoluwa O Okusaga
Jul 31, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kimberly BellPatricia M Whitaker-Azmitia
Apr 27, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R IidaT Nabeshima
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi NishiyamaShigeyoshi Itohara
May 29, 2013·CNS Neuroscience & Therapeutics·Shoji YokoboriRoss Bullock
Oct 22, 2013·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Roberta Candal de MacedoCristiane Ritter
Mar 20, 2003·Microscopy Research and Technique·Matthias RothermundtVolker Arolt
Feb 28, 2001·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·L C PortelaR Giugliani
May 19, 2010·Journal of Neurochemistry·Scoty M HearstParminder J S Vig
Jan 16, 2013·Luminescence : the Journal of Biological and Chemical Luminescence·Huisheng ZhangYuejun Lu
Mar 9, 2006·Behavior Genetics·Zohra SérégazaBernard Soumireu-Mourat
Dec 26, 2001·Brain Research Bulletin·P M Whitaker-Azmitia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.